Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bigotte, L.
Right arrow Articles by Olsson, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bigotte, L.
Right arrow Articles by Olsson, Y.
NEUROLOGY 1987;37:985
© 1987 American Academy of Neurology

Degeneration of trigeminal ganglion neurons caused by retrograde axonal transport of doxorubicin

Luis Bigotte, MD and Yngve Olsson, MD

Laboratory of Neuropathology, Department of Neurology (Dr. Bigotte), Hospital dos Capuchos—Hospitais Civis de Lisboa, Lisbon, Portugal; and the Laboratory of Neuropathology (Dr. Olsson), Institute of Pathology, University of Uppsala, Uppsala, Sweden.

Selective nerve cell degeneration was induced in the trigeminal ganglion of the mouse by injecting doxorubicin (Adriamycin) around intact sensory nerve terminals of the head. The drug apparently reached the neurons by retrograde axonal transport after its uptake in nerve branches. A direct fluorescence microscopic method revealed that the compound accumulated in the neurons. Electronmicroscopy showed degeneration of these cells, beginning in the nucleolus and the nucleus. Doxorubicin injected around sensory nerve terminals appears to be a useful compound for selective destruction of mouse sensory neurons. Retrograde axonal transport of neurotoxic compounds is probably an important pathogenetic mechanism in certain forms of intoxication which give rise to lesions in the nervous system.

Address correspondence and reprint requests to Dr. Bigotte de Almeida, Lab. Neuropatologia, Servico de Neurologia, Hospital Dos Capuchos—Hospitais Civis de Lisboa, Lisboa, Portugal.

Supported by grants from The Swedish Medical Research Council (project 12X-03020), The Swedish Medical Society, Socialstyrelsen, Ahléns, Bergwalls, Trygg Hansa, and Söderbergs stiftelser.

Received March 7, 1986. Accepted for publication in final form September 25, 1986.




This article has been cited by other articles:


Home page
CROBMHome page
G.R. Holland
Experimental Trigeminal Nerve Injury
Critical Reviews in Oral Biology & Medicine, January 1, 1996; 7(3): 237 - 258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.